| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.7 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.056 | 0.7 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |